PINL:GRPOF - Post by User
Post by
tomcpaon May 31, 2018 3:50pm
64 Views
Post# 28107622
Leading biopharmaceutical company P.T 2$ +++
Leading biopharmaceutical company P.T 2$ +++Cannabis preparations exert numerous therapeutic effects. They have: 1) antipastic 2) analgesic 3) antiemetic 4) antiemetic 5) neuroprotective 6) anti-inflammatory actions and are effective againts certain psychiatric diseases. But for now, people who want to take cannabis cannot count on a doctor to approve it it for them.
According to the Canadian and the US drug regulatory agencies, there is no evidence to support the safety and efficacy of marijuana for use in the treatment of pain or any other indication. TBP product development plan would provide the data necessary for drug regulatory agencies to grant marketing approval and physicians to prescribe or recommend its cannabis based products.
INSURANCE: $$$
Insurance companies will only be able to cover the cost of products with Drug Identification Numbers. TBP plans to take the natural aspects of medical cannabis and applies the science of pharma to develop products that patients want, doctors want to prescribe and insurance companies will cover